A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy in Treating Esophageal Carcinoma: A Study at a Tertiary Care Cancer Center in Suburban India

Background and objective Esophageal carcinoma remains a disease associated with high mortality rates among patients even after receiving treatment. Management with surgery alone offers a five-year survival of only 20%. Hence adjuvant and neoadjuvant therapies were instituted to treat this condition...

Descripción completa

Detalles Bibliográficos
Autores principales: Shewalkar, Balaji K, Boralkar, Ajay K, Kaldate, Aditi, Shewalkar, Meghana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358358/
https://www.ncbi.nlm.nih.gov/pubmed/35949733
http://dx.doi.org/10.7759/cureus.26674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358358/
https://www.ncbi.nlm.nih.gov/pubmed/35949733
http://dx.doi.org/10.7759/cureus.26674

Ejemplares similares